Third Harmonic Bio, Inc.
THRD · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | -$0 | -$0 |
| % Margin | – | 50% | – | – |
| R&D Expenses | $11 | $11 | $11 | $8 |
| G&A Expenses | $8 | $6 | $6 | $6 |
| SG&A Expenses | $8 | $6 | $6 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | -$0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19 | $16 | $17 | $14 |
| Operating Income | -$19 | -$16 | -$17 | -$14 |
| % Margin | – | -34,247.9% | – | – |
| Other Income/Exp. Net | $3 | $3 | $3 | $3 |
| Pre-Tax Income | -$16 | -$13 | -$14 | -$11 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$16 | -$13 | -$14 | -$11 |
| % Margin | – | -27,306.3% | – | – |
| EPS | -0.35 | -0.29 | 0.33 | -0.26 |
| % Growth | -20.7% | -187.9% | 226.9% | – |
| EPS Diluted | -0.35 | -0.29 | 0.33 | -0.26 |
| Weighted Avg Shares Out | 45 | 41 | 41 | 41 |
| Weighted Avg Shares Out Dil | 45 | 41 | 41 | 41 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $3 | $3 | $3 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$19 | -$16 | -$17 | -$14 |
| % Margin | – | -34,220.8% | – | – |